---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-113463"
form_type: "8-K"
ticker: "NTRB"
cik: "0001676047"
company_name: "NutriBand Inc."
filed_at: "2024-12-30T23:59:59+00:00"
generated_at: "2026-05-28T22:46:19.607653+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Nutriband extends AVERSA patent to Macao; now covered in 46 countries

## Summary
- Macao IP Office assigned patent number J/9010 with entry date December 17, 2024.
- AVERSA abuse-deterrent technology now patented in 46 countries and territories.
- Company targets FDA submission for AVERSA Fentanyl in first half of 2025.
- AVERSA Fentanyl has potential peak US sales of $80M to $200M per Health Advances report.
- Partnership with Kindeva Drug Delivery for lead product using FDA-approved fentanyl patch system.

## SEC filing metadata
- accession: 0001213900-24-113463
- form_type: 8-K
- ticker: NTRB
- cik: 0001676047
- company_name: NutriBand Inc.
- filed_at: 2024-12-30T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676047/000121390024113463/0001213900-24-113463-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676047/000121390024113463/ea0226333-8k_nutri.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-113463
- JSON: https://secwatch.observer/filing/0001213900-24-113463.json
- Plain text: https://secwatch.observer/filing/0001213900-24-113463.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.